Predictive value of early and late 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib

Kobe C, Scheffler M, Holstein A, Zander T, Nogovam L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Dietlein M, Wolf J, Kahraman D

Journal: European Journal of Nuclear Medicine & Molecular Imaging, Vol 39, No 7, July 2012, doi: 10.1007/s00259-012-2118-8
Veröffentlichung: Juli 2012